Akt activation by Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) in ovarian cancer cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Akt activation by Ca2+/calmodulin-dependent protein kinase kinase 2 (CaMKK2) in ovarian cancer cells
Authors
Keywords
-
Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 292, Issue 34, Pages 14188-14204
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2017-06-21
DOI
10.1074/jbc.m117.778464
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Whole–genome characterization of chemoresistant ovarian cancer
- (2015) Ann-Marie Patch et al. NATURE
- Targeting the translation machinery in cancer
- (2015) Mamatha Bhat et al. NATURE REVIEWS DRUG DISCOVERY
- Nucleoporin 62 and Ca2+/calmodulin dependent kinase kinase 2 regulate androgen receptor activity in castrate resistant prostate cancer cells
- (2015) Loukia G. Karacosta et al. PROSTATE
- AMPK—Sensing Energy while Talking to Other Signaling Pathways
- (2014) D. Grahame Hardie Cell Metabolism
- “Platinum resistant” ovarian cancer: What is it, who to treat and how to measure benefit?
- (2014) Alison Davis et al. GYNECOLOGIC ONCOLOGY
- The Model Muddle: In Search of Tumor Growth Laws
- (2013) P. Gerlee CANCER RESEARCH
- AMPK: A Contextual Oncogene or Tumor Suppressor?
- (2013) J. Liang et al. CANCER RESEARCH
- Dynamic Adipocyte Phosphoproteome Reveals that Akt Directly Regulates mTORC2
- (2013) Sean J. Humphrey et al. Cell Metabolism
- New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential
- (2013) S. Banerjee et al. CLINICAL CANCER RESEARCH
- Diverse Mechanisms of AKT Pathway Activation in Human Malignancy
- (2013) Mitchell Cheung et al. CURRENT CANCER DRUG TARGETS
- Inhibition of Protein Synthesis Alters Protein Degradation through Activation of Protein Kinase B (AKT)
- (2013) Chun-Ling Dai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Development of PI3K inhibitors: lessons learned from early clinical trials
- (2013) Jordi Rodon et al. Nature Reviews Clinical Oncology
- Multiple Genetic Alterations within the PI3K Pathway Are Responsible for AKT Activation in Patients with Ovarian Carcinoma
- (2013) Carmela De Marco et al. PLoS One
- Evaluating cell lines as tumour models by comparison of genomic profiles
- (2013) Silvia Domcke et al. Nature Communications
- Inhibition of PI3K/mTOR Leads to Adaptive Resistance in Matrix-Attached Cancer Cells
- (2012) Taru Muranen et al. CANCER CELL
- A Regulatory Feedback Loop Between Ca2+/Calmodulin-dependent Protein Kinase Kinase 2 (CaMKK2) and the Androgen Receptor in Prostate Cancer Progression
- (2012) Loukia G. Karacosta et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Calcium/Calmodulin-dependent Protein Kinase Kinase 2: Roles in Signaling and Pathophysiology
- (2012) Luigi Racioppi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The Association of PI3 Kinase Signaling and Chemoresistance in Advanced Ovarian Cancer
- (2012) C. P. Carden et al. MOLECULAR CANCER THERAPEUTICS
- Dissecting “PI3Kness”: The Complexity of Personalized Therapy for Ovarian Cancer
- (2012) Robert C. Bast et al. Cancer Discovery
- Akt, FoxO and regulation of apoptosis
- (2011) Xinbo Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis
- (2011) Charles E Massie et al. EMBO JOURNAL
- Genomic Complexity and AKT Dependence in Serous Ovarian Cancer
- (2011) Aphrothiti J. Hanrahan et al. Cancer Discovery
- CaM Kinase Kinase β-Mediated Activation of the Growth Regulatory Kinase AMPK Is Required for Androgen-Dependent Migration of Prostate Cancer Cells
- (2010) Daniel E. Frigo et al. CANCER RESEARCH
- Cell Signaling by Receptor Tyrosine Kinases
- (2010) Mark A. Lemmon et al. CELL
- Targeting the PI3K signaling pathway in cancer
- (2009) Kwok-Kin Wong et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Nuclear cyclin D1: An oncogenic driver in human cancer
- (2009) Jong Kyong Kim et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The mammalian target of rapamycin complex 2 controls folding and stability of Akt and protein kinase C
- (2008) Valeria Facchinetti et al. EMBO JOURNAL
- Regulation of Proline-rich Akt Substrate of 40 kDa (PRAS40) Function by Mammalian Target of Rapamycin Complex 1 (mTORC1)-mediated Phosphorylation
- (2008) Lifu Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- S6K Directly Phosphorylates IRS-1 on Ser-270 to Promote Insulin Resistance in Response to TNF-α Signaling through IKK2
- (2008) Jin Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PI3K/Akt: getting it right matters
- (2008) T F Franke ONCOGENE
- GSK-3β regulates cyclin D1 expression: A new target for chemotherapy
- (2007) Fumi Takahashi-Yanaga et al. CELLULAR SIGNALLING
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started